Tezobell - Bortezomib
Product Description
PTCKD OTTO Pharmaceuticals
-
ID
-
2022On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
PTCKD OTTO Pharmaceuticals
-
ID
-
2022On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from PTCKD OTTO Pharmaceuticals (2)
-
Product Pemecine - Pemetrexed
Composition: Pemetrexed 100 mg & 500 mg
Indication: The treatment of malignant pleural mesothelioma & non-small cell lung cancer
Packed in : Dry vial 100 mg & 500 mg
-
Product Belloxa - Oxaliplatin
Composition Oxaliplatin 50 mg &100 mg
Indication
Adjuvant treatment of stage III colon cancer (Duke stage C) after complete resection of initial tumor, treatment of metastatic colorectal cancer
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance